Condition
Shoulder Arthropathy
Total Trials
6
Recruiting
0
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
2Total
P 4 (2)
Trial Status
Completed3
Unknown2
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05488847Phase 4Active Not RecruitingPrimary
Opioid-Free Pain Protocol After Shoulder Arthroplasty
NCT05940974UnknownPrimary
Quality of Life, Functional Outcomes and Costs in Shoulder Arthroplasty
NCT05170321Unknown
Analysis of Influencing Factors and Construction of Prediction Models of Artificial Joint Replacement in China
NCT01005446Completed
Reverse Shoulder Prosthesis Prospective Multi-Center Study
NCT01937559Phase 4Completed
Topical Tranexamic Acid (TXA) in Joint Arthroplasty
NCT03573765Completed
Epidemiology and Outcomes of Upper Limb Surgery: Analysis of Routine Data
Showing all 6 trials